Recro Pharma Net Profit Margin 2014-2020 | REPH

Recro Pharma net profit margin from 2014 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Recro Pharma Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.08B $-0.03B -34.57%
2020-03-31 $0.10B $-0.03B -26.04%
2019-12-31 $0.10B $-0.02B -19.19%
2019-09-30 $0.10B $-0.05B -50.51%
2019-06-30 $0.09B $-0.06B -64.13%
2019-03-31 $0.08B $-0.07B -83.13%
2018-12-31 $0.08B $-0.08B -101.28%
2018-09-30 $0.08B $-0.06B -78.48%
2018-06-30 $0.08B $-0.06B -74.36%
2018-03-31 $0.07B $-0.05B -73.97%
2017-12-31 $0.07B $-0.05B -69.44%
2017-09-30 $0.07B $-0.04B -51.43%
2017-06-30 $0.07B $-0.03B -45.71%
2017-03-31 $0.07B $-0.03B -44.29%
2016-12-31 $0.07B $-0.03B -43.48%
2016-09-30 $0.07B $-0.01B -13.04%
2016-06-30 $0.07B $-0.01B -8.70%
2016-03-31 $0.07B $0.00B 1.41%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.053B $0.099B
Recro Pharma, Inc. is a clinical stage specialty pharmaceutical company. It develops non-opioid therapeutics for the treatment of pain in the post-operative setting. The company is developing intranasal formulation of Dexmedetomidine (Dex) for the treatment of post-operative pain and cancer breakthrough pain; sublingual formulation of Dex for the treatment of chronic pain; and Fadolmidine (Fado), a product candidate to treat post-operative pain and neuropathic pain. Recro Pharma, Inc. is based in Malvern, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.617B 43.58
Takeda Pharmaceutical (TAK) Japan $59.051B 10.29
Astellas Pharma (ALPMY) Japan $28.374B 14.38
Eisai (ESALY) Japan $26.495B 22.39
UCB SA (UCBJF) Belgium $22.446B 0.00
Merck (MKGAF) Germany $18.572B 24.36
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $13.816B 45.01
Grifols, S.A (GRFS) Spain $11.427B 13.97
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $9.439B 36.54
IPSEN SA ADR (IPSEY) France $9.086B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.993B 13.22
Ionis Pharmaceuticals (IONS) United States $7.232B 45.81
Orion OYJ (ORINY) Finland $7.077B 24.56
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.852B 0.00
United Therapeutics (UTHR) United States $4.711B 10.89
Evotec AG (EVTCY) Germany $4.121B 143.05
FibroGen (FGEN) United States $4.068B 0.00
Hypermarcas (HYPMY) Brazil $3.774B 13.88
ChemoCentryx (CCXI) United States $3.698B 0.00
Nektar Therapeutics (NKTR) United States $3.633B 0.00
PTC Therapeutics (PTCT) United States $3.170B 0.00
Sage Therapeutics (SAGE) United States $3.074B 0.00
Pacira BioSciences (PCRX) United States $2.578B 67.76
Xencor (XNCR) United States $2.374B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.281B 11.04
Corcept Therapeutics (CORT) United States $2.042B 18.80
Revolution Medicines (RVMD) United States $1.899B 0.00
Cronos Group (CRON) Canada $1.889B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.889B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.600B 11.11
USANA Health Sciences (USNA) United States $1.577B 14.86
Heron Therapeutics (HRTX) United States $1.452B 0.00
Zogenix (ZGNX) United States $1.367B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.268B 12.09
Trillium Therapeutics (TRIL) Canada $1.249B 0.00
Indivior (INVVY) United States $1.177B 14.58
Karyopharm Therapeutics (KPTI) United States $1.173B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.135B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.071B 0.00
Translate Bio (TBIO) United States $1.061B 0.00
Esperion Therapeutics (ESPR) United States $1.039B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.951B 592.13
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
VAXART, INC (VXRT) United States $0.806B 0.00
Endo (ENDP) Ireland $0.726B 1.07
ImmunoGen (IMGN) United States $0.721B 0.00
Tilray (TLRY) Canada $0.717B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.701B 0.00
Collegium Pharmaceutical (COLL) United States $0.667B 0.00
Molecular Templates (MTEM) United States $0.652B 0.00
Flexion Therapeutics (FLXN) United States $0.618B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.609B 0.00
Radius Health (RDUS) United States $0.583B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.562B 0.00
Ocular Therapeutix (OCUL) United States $0.555B 0.00
Ardelyx (ARDX) United States $0.552B 0.00
Siga Technologies (SIGA) United States $0.548B 58.42
Aerie Pharmaceuticals (AERI) United States $0.544B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.532B 0.00
Altimmune (ALT) United States $0.456B 0.00
Organogenesis Holdings (ORGO) United States $0.437B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.422B 0.00
Harpoon Therapeutics (HARP) United States $0.413B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.406B 20.23
Akebia Therapeutics (AKBA) United States $0.383B 0.00
Redhill Biopharma (RDHL) Israel $0.382B 0.00
TherapeuticsMD (TXMD) United States $0.368B 0.00
MEI Pharma (MEIP) United States $0.366B 0.00
DURECT (DRRX) United States $0.355B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.354B 8.77
Innate Pharma SA (IPHYF) France $0.324B 0.00
IMV INC (IMV) Canada $0.324B 0.00
PROFOUND MEDICL (PROF) Canada $0.322B 0.00
Jounce Therapeutics (JNCE) United States $0.321B 15.19
Concert Pharmaceuticals (CNCE) United States $0.314B 0.00
Rafael Holdings (RFL) United States $0.276B 0.00
Aquestive Therapeutics (AQST) United States $0.263B 0.00
Xeris Pharmaceuticals (XERS) United States $0.257B 0.00
Calithera Biosciences (CALA) United States $0.250B 0.00
Nature's Sunshine Products (NATR) United States $0.250B 24.60
Lannett Co Inc (LCI) United States $0.242B 5.62
KalVista Pharmaceuticals (KALV) United States $0.240B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.232B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.219B 0.00
CASI Pharmaceuticals (CASI) United States $0.217B 0.00
Heat Biologics (HTBX) United States $0.205B 0.00
OptiNose (OPTN) United States $0.204B 0.00
Nivalis Therapeutics (ALPN) United States $0.193B 0.00
Otonomy (OTIC) United States $0.183B 0.00
Taiwan Liposome (TLC) Taiwan $0.161B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.161B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.155B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.137B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.116B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.108B 0.00
Champions Oncology (CSBR) United States $0.106B 0.00
MediWound (MDWD) Israel $0.103B 0.00
Aclaris Therapeutics (ACRS) United States $0.102B 0.00
Lipocine (LPCN) United States $0.101B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.088B 0.00
Biomerica (BMRA) United States $0.083B 0.00
CTI BioPharma (CTIC) United States $0.082B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.079B 0.00
Hemispherx BioPharma (AIM) United States $0.078B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.077B 0.00
Novan (NOVN) United States $0.071B 0.00
ElectroCore (ECOR) United States $0.070B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.065B 0.00
Addex Therapeutics (ADXN) Switzerland $0.065B 0.00
Infinity Pharmaceuticals (INFI) United States $0.063B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.060B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 30.27
CV Sciences (CVSI) United States $0.050B 0.00
India Globalization Capital (IGC) United States $0.050B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.049B 0.00
Natural Alternatives (NAII) United States $0.049B 0.00
IsoRay (ISR) United States $0.048B 0.00
Onconova Therapeutics (ONTX) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
GTx (ONCT) United States $0.043B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.036B 9.20
ProPhase Labs (PRPH) United States $0.035B 0.00
Neos Therapeutics (NEOS) United States $0.034B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.034B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
AgeX Therapeutics (AGE) United States $0.033B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.031B 0.00
Sundial Growers (SNDL) Canada $0.029B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
Midatech Pharma (MTP) United Kingdom $0.025B 0.00
Vical (BBI) United States $0.023B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Flex Pharma (SLRX) United States $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.017B 25.73
HANCOCK JAFFE (HJLI) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
JanOne (JAN) United States $0.010B 0.00
China SXT Pharmaceuticals (SXTC) China $0.009B 0.00
Shineco (TYHT) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00